NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer ...Middle East

PR Newswire - News
NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer
STANS, Switzerland, April 5, 2021 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system...

Hence then, the article about nls pharmaceutics appoints silvia panigone ph d as chief operating officer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer )

Apple Storegoogle play

Last updated :

Also on site :